載脂蛋白E(APOE)多克隆抗體
Polyclonal Antibody to Apolipoprotein E (APOE)
Apo-E; AD2; Apoprotein; Alzheimer Disease 2(E4-Associated,Late Onset
- 編號(hào)UPAA704Mu01
 - 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
 - 來(lái)源多抗制備
 - 宿主兔
 - 效價(jià)-
 - Ig類型 IgG
 - 純化方式抗原特異性親和純化
 - 標(biāo)記物無(wú)標(biāo)記物
 - 免疫原 RPA704Mu01-載脂蛋白E(APOE)重組蛋白
 - 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
 - 性狀液體
 - 濃度0.5mg/mL
 - 且適物種Rattus norvegicus (Rat,大鼠)
 - 應(yīng)用WB; IHC
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見流式抗體。 - 下載 英文說(shuō)明書 中文說(shuō)明書
 - 規(guī)格 20μl100μl 200μl 1ml 10ml
 - 價(jià)格 ¥ 292 ¥ 680 ¥ 972 ¥ 2430 ¥ 9720
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
該抗體是針對(duì)APOE的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別APOE。
用法
            Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.        
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
            抗體標(biāo)記定制服務(wù)
                    Protein-A/G純化柱
                    細(xì)胞和組織染色液
                    抗體陽(yáng)性對(duì)照品
                    組織/切片定制服務(wù)
                    磷酸化抗體定制服務(wù)
                    免疫印跡(WB)實(shí)驗(yàn)服務(wù)
                    免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
                    免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
                    流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
                    免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
                    免疫熒光(IF)實(shí)驗(yàn)服務(wù)
                    緩沖液
                    DAB顯色試劑盒
                    SABC試劑盒
                    長(zhǎng)臂生物素標(biāo)記試劑盒
                    實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
                            
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| URPA704Mu02 | 載脂蛋白E(APOE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA704Mu01 | 載脂蛋白E(APOE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAA704Mu01 | 載脂蛋白E(APOE)多克隆抗體 | WB; IHC | 
| UPAA704Mu02 | 載脂蛋白E(APOE)多克隆抗體 | WB; IHC | 
| ULAA704Mu81 | 載脂蛋白E(APOE)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. | 
| ULAA704Mu71 | 載脂蛋白E(APOE)多克隆抗體(生物素標(biāo)記) | WB | 
| USEA704Mu | 載脂蛋白E(APOE)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| ULMA704Mu | 載脂蛋白E(APOE)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| UKSA704Mu01 | 載脂蛋白E(APOE)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Seizure - European Journal of Epilepsy | Cerebrospinal fluid apolipoprotein E concentration decreases after seizure [Seizure: PIIS1059131109002441] | 
| Biochimica et Biophysica Acta | Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties [PubMed: 23328279 ] | 
| Medical Oncology | Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma [Pubmed: 23609192] | 
| Diabetes. | Adipocyte Atp-Binding Cassette G1 Promotes Triglyceride Storage, Fat Mass Growth And Human Obesity [Pubmed:25249572] | 
| renal failure | Frequencies of apolipoprotein E alleles in depressed patients undergoing hemodialysis – a case-control study [PubMed: 25707516] | 
| Biochim Biophys Acta | Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism [PubMed: 26515253] | 
| Diabetes | Adipocyte ATP-binding cassette G1 promotes triglyceride storage, fat mass growth, and human obesity [PubMed: 25249572] | 
| Scientific Reports | Adaptive?immunity?against?gut?microbiota?enhances?apoE-mediated?immune?regulation?andreduces?atherosclerosis?and?western-diet-related?inflammation. [pubmed:27383250] | 
| Biochemical Pharmacology? | Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice [Pubmed:30026023] | 
| Oncotarget | Deletion of plasma Phospholipid Transfer Protein (PLTP) increases microglial phagocytosis and reduces cerebral amyloid-β deposition in the J20 mouse?… [Pubmed:29731975] | 
| Proteomics Clinical Applications | Comparative proteomics analysis of serum proteins in gestational diabetes during early and middle stages of pregnancy [Pubmed: 31162828] | 
| Nature Communications | Hepatic HuR modulates lipid homeostasis in response to high-fat diet [Pubmed: 32546794] | 
| VETERINARY PATHOLOGY | Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats [Pubmed: 32880234] | 
| Journal of Clinical Medicine | The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome [33321701] | 
| Cancer Cell Int | Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer [33602229] | 
| Nat Commun | GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity [34853313] | 
| Talanta | Iridium nanoclusters as high sensitive-tunable elemental labels for immunoassays: Determination of IgE and APOE in aqueous humor by inductively coupled?… [Pubmed:35378356] | 
| Analytica Chimica Acta | Gold nanoclusters as elemental label for the sequential quantification of apolipoprotein E and metallothionein 2A in individual human cells of the retinal?… [Pubmed:35361429] | 

                    
                    
                            